NEWER ANTICANCER AGENTS.
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001152:Arsenicals; D003520:Cyclophosphamide; D003609:Dactinomycin; D005472:Fluorouracil; D006801:Humans; D008466:Mechlorethamine; D008558:Melphalan; D008727:Methotrexate; D016685:Mitomycin; D008937:Mitomycins; D009369:Neoplasms / Q000276:immunology*; D010600:Pharmacology; D013256:Steroids; D014265:Triethylenemelamine; D014747:Vinblastine; D014750:Vincristine
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001152:Arsenicals; D008937:Mitomycins; D013256:Steroids; D003609:Dactinomycin; D008466:Mechlorethamine; D016685:Mitomycin; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D014265:Triethylenemelamine; D008558:Melphalan; C100059:oxophenarsine; D005472:Fluorouracil; D008727:Methotrexate
ACTINOMYCIN; ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; FLUOROURACIL; MECHLORETHAMINE OXIDE; MELPHALAN; METHOTREXATE; MITOMYCIN; NEOPLASM IMMUNOLOGY; OXOPHENARSINE; PHARMACOLOGY; REVIEW; STEROIDS; TRIETHYLENE MELAMINE; VINBLASTINE; VINCRISTINE